Publication:
Synthesis, antiproliferative activity targeting lung cancer and in silico studies of hydroxypiperidine substituted thiosemicarbazones

dc.contributor.authorAftab H.
dc.contributor.authorIslam M.
dc.contributor.authorŞenol H.
dc.contributor.authorBatool Z.
dc.contributor.authorAteşoğlu Ş.
dc.contributor.authorÇakır F.
dc.contributor.authorAkbaş F.
dc.contributor.authorTaslimi P.
dc.contributor.authorAlanazi A. K.
dc.contributor.authorNoreen F.
dc.contributor.authoret al.
dc.date.accessioned2025-09-22T21:50:30Z
dc.date.issued2025-09-01
dc.identifier.citationAftab H., Islam M., Şenol H., Batool Z., Ateşoğlu Ş., Çakır F., Akbaş F., Taslimi P., Alanazi A. K., Noreen F., et al., "Synthesis, antiproliferative activity targeting lung cancer and in silico studies of hydroxypiperidine substituted thiosemicarbazones", SCIENTIFIC REPORTS, cilt.15, ss.1-15, 2025
dc.identifier.issn2045-2322
dc.identifier.urihttps://hdl.handle.net/20.500.12645/41161
dc.identifier.volume15
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectEczacılık
dc.subjectMeslek Bilimleri
dc.subjectFarmasötik Kimya
dc.subjectSağlık Bilimleri
dc.subjectPharmacology and Therapeutics
dc.subjectProfessional Sciences
dc.subjectPharmaceutical Chemistry
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (Med)
dc.subjectYaşam Bilimleri (Life)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFarmakoloji ve Eczacılık
dc.subjectClinical Medicine (Med)
dc.subjectLife Sciences (Life)
dc.subjectPharmacology & Toxicology
dc.subjectPharmacology & Pharmacy
dc.subjectFarmakoloji
dc.subjectFarmakoloji, Toksikoloji ve Eczacılık (çeşitli)
dc.subjectGenel Farmakoloji, Toksikoloji ve Eczacılık
dc.subjectFarmakoloji (tıbbi)
dc.subjectİlaç Rehberleri
dc.subjectYaşam Bilimleri
dc.subjectPharmacy
dc.subjectPharmacology
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology (medical)
dc.subjectDrug Guides
dc.subjectLife Sciences
dc.titleSynthesis, antiproliferative activity targeting lung cancer and in silico studies of hydroxypiperidine substituted thiosemicarbazones
dc.typeArticle
dspace.entity.typePublication
local.avesis.id47d1e0ce-f2cd-4407-ab48-9df65d92973a

Files